Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| EFSC | ENTERPRISE FINANCIAL SERVICES CORP | United States | $1.45B | 37,491,713 | 72.09% | 19.65% | Net Selling | Net Selling |
| INTA | INTAPP INC | United States | $2.30B | 72,260,288 | 56.00% | 44.00% | Net Selling | Net Selling |
| SMAR | SMARTSHEET INC | United States | $5.26B | 137,424,128 | 89.13% | 9.59% | Net Selling | Net Selling |
| PWFL | POWERFLEET INC | United States | $168.57M | 37,212,304 | 46.42% | 53.58% | Net Selling | |
| RMBL | RUMBLEON INC | United States | $171.79M | 35,203,241 | 28.53% | 71.47% | Net Buying | |
| SVV | SAVERS VALUE VILLAGE INC | United States | $2.76B | 161,363,892 | 56.27% | 43.73% | Net Selling | Net Buying |
| CFB | CROSSFIRST BANKSHARES INC | United States | $617.31M | 49,345,279 | 56.27% | 17.45% | Net Selling | Net Selling |
| TSQ | TOWNSQUARE MEDIA INC | United States | $203.59M | 16,633,342 | 16.28% | 83.72% | Net Selling | Net Selling |
| XERS | XERIS BIOPHARMA HOLDINGS INC | United States | $245.79M | 140,453,467 | 42.66% | 15.51% | Net Buying | Net Buying |
| CDMO | AVID BIOSERVICES INC | United States | $466.58M | 63,479,794 | 90.14% | 9.06% | Net Selling | |
| WEST | WESTROCK COFFEE CO | United States | $882.98M | 88,033,917 | 36.02% | 63.98% | Net Buying | Net Selling |
| WNS | WNS (HOLDINGS) LTD | India | $1.84B | 45,684,145 | 100.00% | 0.00% | ||
| MRVL | MARVELL TECHNOLOGY INC | United States | $60.29B | 866,000,000 | 69.01% | 30.99% | Net Selling | Net Selling |
| DIN | DINE BRANDS GLOBAL INC | United States | $688.98M | 15,252,945 | 69.66% | 30.34% | Net Buying | Net Selling |
| CSTL | CASTLE BIOSCIENCES INC | United States | $558.33M | 27,449,983 | 84.19% | 15.81% | Net Selling | Net Selling |
| ONEW | ONEWATER MARINE INC | United States | $351.52M | 15,999,876 | 61.24% | 38.76% | Net Selling | Net Selling |
| UMH | UMH PROPERTIES INC | United States | $1.09B | 69,342,865 | 73.47% | 11.15% | Net Buying | Net Buying |
| SAIA | SAIA INC | United States | $11.40B | 26,588,162 | 93.71% | 6.29% | Net Selling | Net Selling |
| IMCR | IMMUNOCORE HOLDINGS PLC | United Kingdom | $2.91B | 49,820,613 | 75.26% | 0.07% | Net Buying | Net Buying |
| KPTI | KARYOPHARM THERAPEUTICS INC | United States | $121.97M | 115,067,083 | 63.84% | 32.73% | Net Selling | Net Selling |
| ZTS | ZOETIS INC | United States | $72.54B | 457,867,115 | 92.81% | 5.62% | Net Selling | Net Selling |
| ADMA | ADMA BIOLOGICS INC | United States | $1.49B | 228,220,236 | 74.12% | 24.57% | Net Selling | Net Selling |
| WYNN | WYNN RESORTS LTD | United States | $10.75B | 112,078,263 | 61.95% | 21.99% | Net Selling | Net Selling |
| BW | BABCOCK & WILCOX ENTERPRISES INC | United States | $93.06M | 89,480,435 | 23.83% | 76.17% | Net Buying | Net Buying |
| PRPL | PURPLE INNOVATION INC | United States | $162.43M | 107,212,305 | 59.23% | 40.77% | Net Buying | Net Selling |
| HTHT | H WORLD GROUP LTD | China | $12.66B | 3,159,046,350 | 4.80% | 0.00% | ||
| CXM | SPRINKLR INC | United States | $3.26B | 273,199,226 | 42.44% | 57.56% | Net Selling | Net Selling |
| CWH | CAMPING WORLD HOLDINGS INC | United States | $1.81B | 84,538,038 | 44.37% | 22.04% | Net Selling | Net Selling |
| STKS | ONE GROUP HOSPITALITY INC | United States | $163.11M | 31,307,407 | 23.95% | 76.05% | Net Buying | Net Buying |
| LVS | LAS VEGAS SANDS CORP | United States | $33.86B | 745,047,150 | 6.83% | 93.17% | Net Selling | Net Selling |
| ASLE | AERSALE CORP | United States | $360.82M | 51,990,947 | 36.78% | 63.22% | Net Selling | Net Buying |
| BHVN | BIOHAVEN LTD | United States | $3.18B | 81,579,914 | 79.08% | 20.92% | Net Buying | Net Buying |
| VYGR | VOYAGER THERAPEUTICS INC | United States | $413.77M | 54,300,627 | 47.14% | 52.86% | Net Selling | Net Selling |
| IHS | IHS HOLDING LTD | United Kingdom | $1.17B | 331,920,002 | 14.21% | 0.00% | ||
| MSTR | MICROSTRATEGY INC | United States | $21.76B | 16,968,125 | 47.95% | 0.65% | Net Selling | Net Selling |
| RAMP | LIVERAMP HOLDINGS INC | United States | $2.16B | 66,183,731 | 55.37% | 44.63% | Net Selling | Net Selling |
| ALIT | ALIGHT INC | United States | $5.13B | 562,982,418 | 72.90% | 27.10% | Net Selling | Net Selling |
| ACHV | ACHIEVE LIFE SCIENCES INC | United States | $157.90M | 34,251,911 | 7.96% | 27.78% | Net Buying | Net Selling |
| LRMR | LARIMAR THERAPEUTICS INC | United States | $410.87M | 63,800,017 | 42.05% | 57.95% | Net Buying | Net Buying |
| GM | GENERAL MOTORS CO | United States | $52.30B | 1,140,958,039 | 85.89% | 14.11% | Net Selling | Net Selling |
| CABA | CABALETTA BIO INC | United States | $531.14M | 48,241,615 | 92.00% | 8.00% | Net Buying | |
| TNGX | TANGO THERAPEUTICS INC | United States | $793.98M | 106,718,315 | 59.42% | 40.58% | Net Buying | Net Selling |
| INZY | INOZYME PHARMA INC | United States | $274.27M | 61,771,977 | 54.64% | 45.36% | Net Buying | Net Selling |
| CALC | CALCIMEDICA INC | United States | $58.53M | 10,740,115 | 2.26% | 97.74% | Net Buying | Net Buying |
| GETY | GETTY IMAGES HOLDINGS INC | United States | $1.59B | 405,870,456 | 26.03% | 73.97% | Net Selling | Net Selling |
| BLTE | BELITE BIO INC | United States | $1.16B | 29,149,444 | 0.53% | 0.00% | ||
| APGE | APOGEE THERAPEUTICS INC | United States | $2.39B | 50,655,671 | 82.46% | 11.78% | Net Buying | |
| VKTX | VIKING THERAPEUTICS INC | United States | $8.19B | 110,268,210 | 69.23% | 9.05% | Net Selling | Net Selling |
| SRRK | SCHOLAR ROCK HOLDING CORP | United States | $1.13B | 77,866,281 | 60.56% | 39.44% | Net Buying | Net Selling |
| IVVD | INVIVYD INC | United States | $256.33M | 119,221,230 | 37.84% | 62.16% | Net Selling | |
| LNTH | LANTHEUS HOLDINGS INC | United States | $4.49B | 68,525,556 | 53.56% | 46.44% | Net Selling | Net Selling |
| IRWD | IRONWOOD PHARMACEUTICALS INC | United States | $1.22B | 156,528,648 | 72.14% | 27.86% | Net Selling | Net Selling |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | United States | $1.81B | 171,190,389 | 0.00% | 100.00% | Net Buying | Net Buying |
| LBPH | LONGBOARD PHARMACEUTICALS INC | United States | $710.26M | 36,017,249 | 45.89% | 0.09% | Net Selling | |
| CSGS | CSG SYSTEMS INTERNATIONAL INC | United States | $1.42B | 29,443,284 | 92.53% | 7.47% | Net Selling | Net Selling |
| SIMO | SILICON MOTION TECHNOLOGY CORP | Taiwan | $2.42B | 132,215,732 | 19.50% | 0.00% | ||
| TCBK | TRICO BANCSHARES | United States | $1.13B | 33,268,102 | 39.02% | 60.98% | Net Selling | Net Selling |
| W | WAYFAIR INC | United States | $6.26B | 120,359,931 | 82.58% | 17.42% | Net Selling | Net Selling |
| IMAB | I-MAB | China | $148.80M | 190,033,689 | 6.50% | 0.00% | ||
| SLDB | SOLID BIOSCIENCES INC | United States | $339.06M | 37,756,877 | 21.64% | 78.36% | Net Buying | Net Selling |
| CHUY | CHUY's HOLDINGS INC | United States | $525.77M | 17,335,062 | 39.37% | 60.63% | Net Selling | Net Selling |
| LINC | LINCOLN EDUCATIONAL SERVICES CORP | United States | $321.09M | 31,759,322 | 14.66% | 85.34% | Net Selling | Net Selling |
| PCVX | VAXCYTE INC | United States | $6.58B | 108,407,730 | 83.78% | 16.22% | Net Buying | Net Buying |
| QCRH | QCR HOLDINGS INC | United States | $943.93M | 16,792,880 | 69.97% | 11.13% | Net Buying | Net Buying |
| KURA | KURA ONCOLOGY INC | United States | $1.50B | 76,136,963 | 90.77% | 9.23% | Net Buying | Net Selling |
| STLA | STELLANTIS NV | United Kingdom | $74.79B | 3,023,168,321 | 32.60% | 0.00% | ||
| JBL | JABIL INC | United States | $14.26B | 120,597,316 | 64.87% | 35.13% | Net Selling | Net Selling |
| PRME | PRIME MEDICINE INC | United States | $530.73M | 119,939,247 | 32.55% | 67.45% | Net Buying | Net Buying |
| NKTX | NKARTA INC | United States | $339.49M | 49,416,186 | 53.86% | 46.14% | Net Buying | Net Buying |
| OLMA | OLEMA PHARMACEUTICALS INC | United States | $556.35M | 55,914,741 | 71.71% | 28.29% | Net Buying | Net Selling |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | United States | $784.82M | 70,960,165 | 73.56% | 26.44% | Net Buying | Net Selling |
| DCOM | DIME COMMUNITY BANCSHARES INC | United States | $740.82M | 38,826,981 | 75.34% | 11.71% | Net Selling | Net Selling |
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | United States | $1.30B | 87,384,856 | 54.70% | 45.30% | Net Buying | Net Selling |
| GEF | GREIF INC | United States | $2.92B | 47,121,156 | 50.82% | 48.84% | Net Selling | Net Selling |
| KRRO | KORRO BIO INC | United States | $504.82M | 8,021,946 | 18.90% | 81.10% | Net Buying | Net Buying |
| CELC | CELCUITY INC | United States | $484.81M | 30,453,120 | 52.40% | 15.32% | Net Selling | Net Selling |
| MQ | MARQETA INC | United States | $2.78B | 513,811,111 | 60.20% | 0.58% | Net Selling | Net Selling |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | United States | $1.16B | 49,778,127 | 83.80% | 16.20% | Net Buying | Net Selling |
| KD | KYNDRYL HOLDINGS INC | United States | $4.48B | 230,103,348 | 71.45% | 20.82% | Net Buying | |
| TTGT | TECHTARGET INC | United States | $785.03M | 28,546,634 | 40.90% | 59.10% | Net Selling | Net Selling |
| DNTH | DIANTHUS THERAPEUTICS INC | United States | $630.96M | 29,346,760 | 24.91% | 75.09% | Net Buying | |
| CNNE | CANNAE HOLDINGS INC | United States | $1.45B | 72,481,945 | 81.39% | 17.96% | Net Selling | Net Selling |
| SNDX | SYNDAX PHARMACEUTICALS INC | United States | $1.79B | 84,965,486 | 91.35% | 8.65% | Net Buying | Net Buying |
| ACDC | PROFRAC HOLDING CORP | United States | $1.31B | 159,594,192 | 12.73% | 80.30% | Net Buying | Net Buying |
| IMVT | IMMUNOVANT INC | United States | $3.95B | 145,292,970 | 44.83% | 55.17% | Net Buying | Net Selling |
| HCAT | HEALTH CATALYST INC | United States | $353.13M | 58,563,005 | 74.87% | 25.13% | Net Selling | Net Selling |
| TGI | TRIUMPH GROUP INC | United States | $1.05B | 76,866,074 | 92.22% | 7.78% | Net Selling | Net Buying |
| PBPB | POTBELLY CORP | United States | $314.67M | 29,602,526 | 34.68% | 65.32% | Net Selling | Net Selling |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $129.57M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| SVRA | SAVARA INC | United States | $609.23M | 138,148,141 | 32.26% | 67.74% | Net Buying | Net Selling |
| MYPS | PLAYSTUDIOS INC | United States | $305.11M | 136,208,564 | 27.59% | 42.85% | Net Selling | Net Selling |
| ATLX | ATLAS LITHIUM CORP | United States | $187.33M | 12,769,581 | 15.50% | 62.12% | Net Buying | Net Selling |
| TPST | TEMPEST THERAPEUTICS INC | United States | $78.56M | 22,192,026 | 4.15% | 95.85% | ||
| BOLD | BOUNDLESS BIO INC | United States | N/A | 22,239,333 | 0.00% | 23.98% | Net Buying | Net Buying |
| OMCL | OMNICELL INC | United States | $1.28B | 45,915,296 | 95.18% | 4.82% | Net Selling | Net Selling |
| ACRV | ACRIVON THERAPEUTICS INC | United States | $191.51M | 22,636,951 | 46.35% | 53.65% | Net Buying | Net Buying |
| GT | GOODYEAR TIRE & RUBBER CO | United States | $3.36B | 283,954,995 | 84.13% | 1.39% | Net Selling | Net Selling |
| IVA | INVENTIVA SA | France | $169.38M | 52,115,807 | 9.33% | 0.00% | ||
| ORGO | ORGANOGENESIS HOLDINGS INC | United States | $310.11M | 131,963,176 | 6.24% | 93.76% | Net Selling | Net Selling |
| VRNA | VERONA PHARMA PLC | United Kingdom | $1.25B | 646,524,958 | 10.44% | 55.94% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.